Metabolic effects of TIO2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes by Tucci, P et al.
OPEN
Metabolic effects of TiO2 nanoparticles, a common
component of sunscreens and cosmetics, on human
keratinocytes
P Tucci*,1,2, G Porta3, M Agostini1, D Dinsdale1, I Iavicoli4, K Cain1, A Finazzi-Agro´5, G Melino1,5 and A Willis*,1
The long-term health risks of nanoparticles remain poorly understood, which is a serious concern given their prevalence in the
environment from increased industrial and domestic use. The extent to which such compounds contribute to cellular toxicity is
unclear, and although it is known that induction of oxidative stress pathways is associated with this process, the proteins and
the metabolic pathways involved with nanoparticle-mediated oxidative stress and toxicity are largely unknown. To investigate
this problem further, the effect of TiO2 on the HaCaT human keratinocyte cell line was examined. The data show that although
TiO2 does not affect cell cycle phase distribution, nor cell death, these nanoparticles have a considerable and rapid effect on
mitochondrial function. Metabolic analysis was performed to identify 268 metabolites of the specific pathways involved and 85
biochemical metabolites were found to be significantly altered, many of which are known to be associated with the cellular stress
response. Importantly, the uptake of nanoparticles into the cultured cells was restricted to phagosomes, TiO2 nanoparticles did
not enter into the nucleus or any other cytoplasmic organelle. No other morphological changes were detected after 24-h
exposure consistent with a specific role of mitochondria in this response.
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Normal-sized (4100nm) titanium dioxide (TiO2) particles are
classified as biologically inert in both humans and animals,1,2
and therefore, they have been extensively used as an
excipient in wide range of products such as cosmetics and
pharmaceuticals.3–5 However, in recent years, with the
introduction of nanotechnology, the industrial use of TiO2 in
nanoparticulate form (o100nm) has grown exponentially.
Currently, TiO2 nanoparticles (TiO2-NP) are used as additives
in sunscreen products, paints, printing ink, rubber, paper,
sugar, cement, toothpaste, film, bio-medical ceramic and
implanted biomaterials, antimicrobial plastic packaging and
self-cleaning sanitary ceramics.6–8
Owing to their widespread use, the potential biological
effects of TiO2-NP have assumed increasing importance, and
concerns are mounting for health risks to exposed workers as
well as to the general population. Some studies suggest that
nanoparticles may be more toxic than larger particles of the
samematerial because of their larger surface area, enhanced
chemical reactivity and easier cellular penetration.9 In support
of this, TiO2-NP are known to exert significant toxic effects and
have been shown to cause chronic pulmonary inflammation in
rats10 and pro-inflammatory effects in human endothelial
cells.11 TiO2-NP have also been reported to elicit changes in
gene expression pathways, including apoptosis-related
genes12,13 and inflammatory genes, and to promote oxidative
stress and DNA damage responses.11,12 In vivo studies
suggest that the major pathogenic mechanisms initiated by
TiO2-NP are inflammatory responses and as a consequence,
inflammation is used as a marker for toxicological testing
for TiO2.
14,15
The biological effects of TiO2-NP exposure and the
mechanisms underlining the response are still not well
understood. Therefore, a more detailed understanding of the
toxicological behavior of TiO2-NP is required to elucidate
toxicity pathways, the oxidative stress effects and the
response mechanisms triggered by this material. In particular,
as skin contact is one of the most significant routes of
exposure for the general population, as well as in workers
occupationally exposed to this agent, it is very important to
evaluate the interaction between TiO2-NP and keratinocytes.
The aim of this study was therefore to investigate the early
pathological, metabolic and toxicological processes induced
by TiO2-NP through a new, non-invasive and powerful
technique, metabolomics. This method provides a relatively
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complete biological outlook of the whole-cell response to
nanomaterials. We conducted such a metabolic analysis in a
human keratinocyte cell line (HaCaT cells) treated for 24 h
with a range of doses of TiO2-NP, in order to characterize the
metabolic effects of treatment and to obtain a detailed
biochemical identification of tissue damage.
Results
Ultrastructural effects of TiO2. The size and shape and
particle surface characteristics, for example, charge, are
important factors in cytotoxicity.16 In addition, TiO2 particles
are mostly found as aggregates,17 and the nature of these
aggregates is an important factor in determining their
cytotoxicity;18 in this regard, it has been shown previously
that the size of TiO2 aggregates affects gene expression
pathways.19 To determine whether and how TiO2-NP were
taken up by the cells, electron microscopy was used to
examine their interaction with HaCaT cells. Electron-dense
particles of 10–100 nm in diameter were identified both
isolated and as aggregates within phagosomes throughout
the cytoplasm (Figure 1a). Larger phagosomes (1–2 mm in
diameter) were particularly common in the region of the
microtubule-organizing center and their titanium content was
confirmed by energy-dispersive X-ray spectrometry. No
particles were found in any other cytoplasmic organelles or
within the nucleus, and no other morphological changes were
detected after 24-h exposure (Figure 1a). Several large
clumps of particles (0.5–3 mm in diameter) were observed
free in the culture medium, however, none of these were
found to be undergoing phagocytosis.
Effect of TiO2 on cell viability and on mitochondrial
function. In order to determine whether there were cytotoxic
effects associated with the presence of intracellular TiO2-NP,
HaCaT cells were exposed to a range of concentrations of
nanoparticles and apoptosis rates were examined by FACS
analysis (Figure 1b). The data show that there were no
significant differences in cell death between cells treated with
TiO2 and control cells within the time frame used (Figure 1b).
Moreover, there were no significant differences in the cell
cycle profile.
As intracellular TiO2-NP did not cause any gross changes in
cell cycle phase distribution or induce apoptosis during the
time interval of study, a more refined analysis was performed.
In particular, the role of mitochondrial function was investi-
gated as a reduction inmitochondrial activity is known to be an
early marker of toxic insult. Previous studies have shown that
energy pathways are highly sensitive to exposure to toxic
agents, affecting several intracellular biochemical processes
(glycolysis, Krebs cycle, electron transport and OXPHOS),
resulting in the abnormal production of ATP and release of
heat and chemical byproducts (lactate and CO2) into the
extracellular environment.20–26 In order to evaluate
whether TiO2-NP affected mitochondrial function, the oxygen
consumption rate (OCR) (Figure 2a and Supplementary
Figure S1A) and extracellular acidification rate (ECAR)
(Supplementary Figure S1B) were measured in HaCaT cells
exposed sequentially to modulators of mitochondrial activity
(oligomycin, FCCP and Rotenone) in the presence of different
concentrations of TiO2-NP for 24 h.
The data show that TiO2-NP led to a significant, inhibitors-
insensible, concentration-dependent increase of basal cellu-
lar respiration (Figure 2b). In particular, the rotenone-sensitive
OCR was affected by TiO2-NP (Figure 2c). Thus, in control
cells, rotenone reduced the OCR to about 20% of its baseline
rate, suggesting that mitochondrial respiration accounted for
B80% of total cellular respiration. However, in cells exposed to
TiO2-NP, the oxygen consumption was reduced by rotenone to
between 60 and 30% of the total. Taken together, these data
strongly suggest that TiO2-NP affects mitochondrial function,
inducing a significant fraction of electrons to escape from the
regular respiratory chain path, perhaps giving rise to reactive
oxygen radicals. Trying to better understand these effects in
more detail, a full metabolic analysis was carried out.
High-dose TiO2 has an impact on energy metabolism
and increases cellular turnover. HaCaT cells were
incubated with 5, 50 or 100mg/ml TiO2-NP for 24 h and
samples were analyzed by either gas chromatography/mass
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Figure 1 Effect of TiO2 on morphology and cell cycle phase distribution.
(a) Transmission electron microscopy of HaCaT cells treated with 50 mg/ml TiO2 for
24 h. Agglomerated and single particles were found inside phagosomes/lysosomes.
No particles were found within the nucleus or any other organelles. (b) Apoptosis
and cell cycle analysis was performed by flow cytometry in HaCat cells treated
for 24 h with different concentrations of TiO2 as indicated. Data represent
mean±S.E.M. of three independent experiments
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spectrometry (GC/MS) or liquid chromatography/mass spec-
trometry (LC/MS/MS). Overall, a total of 268 metabolites
were identified (Table 1 and Supplementary Figure S3,) of
which 56 or 85 (Table 1, at 50 or 100mg/ml versus control,
Pr0.05 and 0.05oPo0.10, respectively) were found
significantly altered by exposure to TiO2-NP.
After treatment with the highest concentration of TiO2,
NADþ (Figure 3a), NADH (Figure 3b), and NADPþ
(Figure 3c) levels were decreased following exposure of cells
to 100 mg/ml TiO2. There was a reduction in the amount of
coenzyme A (Figure 3d), carnitine (Figure 3e) and acyl-
carnitines (Figures 3f-g), implying an alteration in the oxidation
of fatty acids, and changes in acetyl-CoA (Figure 3h) and
acetyl-carnitine (Figure 3i).
Although TCA intermediates did not appear to be affected
(3-phosphoglycerate, Figure 4b) by exposure of the cells to
TiO2-NP, glucose (Figure 4a) and glycolytic metabolites,
including pyruvate (Figure 4c), were significantly reduced at
higher doses of TiO2. Consistent with these data, there was
also a reduction in pentose phosphate pathway intermediates,
such as ribose-5-phosphate (Figure 4d) and ribose
(Figure 4e). As these intermediates are important for
nucleotide synthesis,27,28 reduced ribose-5-phosphate may
explain the lower level of nucleosides and nucleotides
observed at 100mg/ml TiO2-NP.
Reduced nucleotide synthesis may drive an increase of
RNA turnover as indicated by elevated RNA degradation
metabolites (30AMP, 30CMP, and 20, 30-cCMP) (Figures 5a-c)
after treatment with 50 mg/ml and 100mg/ml TiO2. Similarly,
dipeptides were significantly increased (Figures 5d-f), indicat-
ing a faster protein degradation and turnover.
Altogether, these changes indicate that TiO2-NP have
significant effects on anabolic pathways and energy
metabolism.
TiO2 nanoparticles affect methylation capacity, resulting
in decreased glutathione levels. S-Adenosylmethionine
(SAM) and S-Adenosylhomocysteine (SAH) are metabolites
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Figure 2 Effect of TiO2 on respiration. (a) OCR of HaCat cells exposed sequentially to each modulator of mitochondrial activity (oligomycin, FCCP and Rotenone) in
presence of different concentrations of TiO2 for 24 h. A representative experiment out of five performed, is shown. (b) Basal cellular respiration for each concentration used, as
from experiment in A. (c) Effect of TiO2 on rotenone-sensitive OCR, as from experiment in (a). Data in (b and c) represent mean±S.E.M. of three independent experiments.
Statistical P-values in (b) and (c) are shown, compared with control. See also Supplementary Figures 1 for relative cumulative effect on three independent experiments and for
ECAR
Table 1 Metabolic changes induced by TiO2
Statistical Comparisons
Welch’s two-
sample
t-tests
Total
number
of bio-
chemicals
with
Pp0.05
Bio-
chemicals
(mk)
Pp0.05
Total
number
of bio-
chemicals
with
0.05o
Po0.10
Bio-
chemicals
(mk)
0.05o
Po0.10
5 mg/CTRL 19 19/0 11 6/5
50mg/CTRL 45 39/6 11 8/3
100mg/CTRL 54 17/37 31 2/29
50mg/5mg 59 49/10 31 28/3
100mg/5 mg 71 26/45 29 2/27
100mg/50mg 56 0/56 53 1/52
Welch’s two-sample t-test was used to determine whether the means of the two
populations are different. A total of 268 metabolites was identified. Bold values
indicate an increase, italic values indicate a reduction. Original data are shown
in Supplementary Figure S3.
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involved in the conversion of methionine to homocysteine in
the proximal part of the methionine cycle. S-Adenosylmethio-
nine is synthesized from methionine and ATP in a reaction
catalyzed by methionine adenosyltransferase. SAM provides
methyl groups in dozens of transmethylation reactions of
crucial biological importance.29 S-Adenosylhomocysteine,
produced by methyl group transfer has been demonstrated
to inhibit these reactions at various concentrations.29–31 The
results obtained show a reduced SAH concentration follow-
ing treatment of HaCaT cells with 50 and 100mg/ml TiO2
(Figure 6a), as well as a decreased level of homocysteine
(Figure 6b), which may react with adenosine to form SAH by
the reverse action of the enzyme S-Adenosylhomocysteine
hydrolase. Moreover, a decreased methylation capacity may
mirror a decreased glutathione synthesis, (Figure 6c) thus
contributing to a greater oxidative stress. Methionine is
essential also for cell growth, being a precursor for the
aminopropyl moieties of spermidine and spermine, the key
polyamines required for transcription and translation, and
which stimulate normal and neoplastic cell division. There-
fore, treatment with TiO2-NP resulted in dysfunction of the
methionine cycle and methionine deficiency (Figure 6d).
Overall gene expression can be regulated by epigenetic
processes including the methylation of cytosine residues in
the DNA sequence of gene promoters.32 This process of DNA
methylation is regulated by the ratio of SAM and SAH, and is
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Figure 3 Effect of TiO2 on energy metabolism and cellular turnover. Levels of NAD
þ (a), NADH (b), NADPþ (c), CoA (d), carnitine (e), hexanoylcarnitine (f),
palmitoylcarnitine (g), acetyl-CoA (h) and acetyl-carnitine (i) were measured as described in Materials and Methods. The box and whiskers legend are shown
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catalyzed by DNA methyltranferase enzymes that transfer
methyl groups from SAM to cytosines. Methionine and folate
interrelate in this metabolic process at the stage of conversion
of homocysteine to methionine. Dysregulation of DNA
methylation has been consistently associated with cancer
initiation. Together with the dose-dependent decrease in
5-methylthioadenosine (MTA) (Figure 7a), these observations
suggest a potential deficiency in the methyl donor SAM. Such
a deficiency could have significant impact on enzymatic
reactions that use SAM as a cofactor, including DNA
methylation enzymes.
A significant dose-dependent decline in cystathionine
(Figure 6e) was also observed in TiO2-treated samples
starting at 50 mg/ml. Cystathionine is an intermediate in
cysteine biosynthesis, which appears to decrease after
treatment with the 100-mg/ml TiO2 dose (Figure 6f). This
reduction in cysteine levels may have a subsequent effect on
glutathione synthesis, which is also reduced at the highest
dose of TiO2 tested (Figure 6c). Glutathione has an important
role in redox-homeostasis; thus, oxidative stress is expected
to increase as glutathione levels decrease.
Highly elevated dimethylarginine (Figure 7b) after treatment
with 50 mg/ml or 100mg/ml of TiO2 would support increased
oxidative stress, as degradation of this regulator of nitric oxide
synthesis is inhibited under such conditions.
TiO2 reduces polyamine synthesis and induces an
inflammatory-like response. The natural polyamines,
spermine and spermidine, as well as their precursor,
putrescine, are aliphatic cations that interact with nucleic
acids and proteins. Spermine and spermidine have a vital
role in a variety of intracellular processes including gene
transcription, RNA processing and translation.33 Increased
polyamine levels are required for growth, differentiation and
transformation of cells. Both spermine and spermidine are
actively involved in the protection of cells from oxidative
stress by scavenging ROS.34–36 Consequently, any imbal-
ance of polyamine metabolism may have important con-
sequences. Thus, for example, increased polyamine
synthesis is a marker of neoplastic proliferation.37–39
A significant dose-dependent decrease in spermidine
(Figure 7c) and the byproduct of spermidine synthesis,
MTA, (Figure 7a) was observed in TiO2-treated cells.
Decreased spermidine synthesis, which is often correlated
with proliferation, may reflect decreased activity of spermidine
synthase due to low levels of decarboxylated SAM. Alter-
natively, reduced levels of the precursor putrescine
(Figure 7d), resulting from lower activity of the urea cycle,
may lead to reduced polyamine synthesis. Increased arginine
levels (Figure 7e) at the 50 and 100mg/ml doses and
decreased urea (Figure 7f) and ornithine (Figure 7g) would
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Figure 4 Effect of TiO2 on glucose metabolism. Levels of glucose (a), 3-phosphoglycerate (b), pyruvate (c), ribose-5-phosphate (d) and ribose (e) were measured as
described in Materials and Methods. The metabolic pathway is shown
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be consistent with the hypothesis that decreased polyamine
synthesis may signify reduced proliferation.
2-(D)-Hydroxy fatty acids are conventional lipid compo-
nents and are important constituents of animal sphingoli-
pids.40–46 The hydroxyl group is believed to add to the
hydrogen-bonding capacity of the sphingolipids, helping to
stabilize membrane structures and strengthen their interac-
tions with membrane proteins. Although 2-hydroxy fatty acids
are not typical indicators of oxidative stress, increased levels
of the fatty acid 2-hydroxypalmitate at the 50 mg/ml and
100mg/ml concentrations (Supplementary Figure S2A) may
reflect increased oxidation of membrane lipids. Furthermore,
a cellular response to stress is also indicated by the increased
levels of the pro-inflammatory molecules prostaglandin E2
(Supplementary Figure S2B) and 15-HETE (Supplementary
Figure S2C).
Taken together, these biochemical changes support a
significant perturbation of the urea cycle and of polyamine
metabolism upon TiO2-NP treatment, as well as some
evidence for an increased inflammatory response.
The glucuronidation pathway is impaired in cells treated
with TiO2. All major enzymes that are involved in the
metabolism of xenobiotics are present in the skin.47 Indeed,
bioactivation of drugs to chemically reactive metabolites is
thought to be the primary step in many chemical toxicities.48
Glucuronidation involves the conjugation of a suitable
functional group present on a variety of structurally unrelated
substrates with glucuronic acid and has an important
cytoprotective role. The reaction requires UDP-glucuronate
as cofactor and is catalyzed by the enzyme UGT. This
metabolic pathway leads to the formation of water-soluble
metabolites. Thus, glucuronate is a highly polar molecule that
is incorporated into proteoglycans, as well as combined with
bilirubin and steroid hormones; it can also be combined with
certain drugs to increase their solubility. Glucuronate is
derived from glucose in the uronic acid pathway. The
pathway involves the oxidation of glucose-6-phosphate to
UDP-glucuronate, and is an alternative mechanism for the
oxidation of glucose that does not provide a means of
producing ATP, but is utilized for the generation of the
activated form of glucuronate, UDP-glucuronate. Glucuroni-
dation of drugs and hormones increases their water solubility
by modifying the substrate with a glucuronate moiety
transferred from UDP-glucuronate. Interestingly, a significant
decrease in UDP-glucuronate (Figure 8a) and glucuronate
(Figure 8b) was observed in cells treated with 100 mg/ml
TiO2, suggesting that this pathway is also affected by
nanoparticle treatment.
Discussion
The skin is the largest organ and represents the body’s
protective surface as the first and outermost contact site for
topically applied substances.49–53 Although the role of the skin
as a barrier in preventing mechanical and physical harm has
often been emphasized, its potential to detoxify chemicals has
been less well studied. However, the skin has a key role in
controlling not only the penetration and distribution but also
the metabolism of topically applied chemicals, and is thus a
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Figure 5 Effect of TiO2 on energy intermediates. Metabolic changes in proteins and in the RNA degradation pathway following treatment with TiO2. Levels of 3-AMP (a),
3-CMP (b), cytosine-2,3-cyclic monophosphate (c), glycylvaline (d), aspartylleucine (e) and aspartylphenylalanine (f) were measured as described in Materials and Methods
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first-pass organ for penetrating substances. Numerous
examples exist showing that skin metabolism is not only
protective but also contributes to skin pathologies such as
contact dermatitis or carcinogenesis.54,55 This implies the
need of safety assessment for all ingredients of cosmetic
products, and the need to employ appropriate models to test
chemical ingredients for their potential to cause skin irritation
and sensitization, as well as genotoxic damage.
Among the engineered nanoparticles, TiO2-NP are the
earliest industrially produced nanomaterials and remain the
most widely used white pigments in use today. Their opacity is
utilized to enhance the whiteness of products such as
toothpaste, lotion, skimmed milk, cottage cheese and
medicines. The levels of TiO2-NP in these different agents
varies over a wide range, being up to 5 mg/ml in foodstuffs,
between 1 and 90 mg/ml in topically applied agents such as
toothpastes and sunscreens, to4100 mg/ml in some paints.56
Because of this wide range of concentrations, we have used a
similarly broad range of concentrations in our study.
Owing to their widespread use, TiO2-NP have become an
important public health issue, and an appropriate risk
assessment of these materials is required due to increased
environmental and occupational exposure. For these rea-
sons, in the last decade, several in vitro and in vivo studies
have been conducted to investigate the potential toxicological
effects of TiO2-NP exposure. Although the findings of in vitro
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studies have to be interpreted with caution because of
heterogeneity in particle characterization and doses of
TiO2-NP used, they do show that TiO2-NP can exert toxic
effects in different cell lines. In particular, they are able to cause
cellular responses, including cell death, cytokine production,
increase of inflammatory indices and radical oxygen species
(ROS) generation.7,14 Nevertheless, the biological effects of
TiO2-NP exposure, and the mechanisms underlying cellular
responses are far from being completely understood.
In this study, we have identified a number of metabolic
changes in response to TiO2 treatment, and focused on
biochemicals that changed significantly in either a dose-
dependent manner or were affected at the highest concentra-
tion of TiO2-NP. Although there is some conflicting evidence in
the literature, several studies have reported cellular toxicity
and induction of oxidative stress upon treatment of mamma-
lian cells with TiO2 in vitro. Our own data would support these
findings, as we have identified several biochemical changes
indicative of oxidative stress and depressed energy metabo-
lism induced by exposure of HaCaT cells to TiO2-NP.
Inflammation leads to genotoxic events as well as cellular
proliferation and tissue remodeling, which are processes that
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increase the likelihood of mutation and progression towards
neoplastic lesions.57 Similarly, ROS generation has also been
implicated in malignant transformation and cancer,58 and
specifically in the acquisition of a tumorigenic phenotype
induced by TiO2-NP.
59 However, the mutagenic or epigenetic
mechanisms underlying the role of TiO2-NP in the multistep
process of carcinogenesis still requires more detailed
analysis.
In summary, we report several significant biochemical
changes associated with the treatment of human keratino-
cytes with TiO2-NP that warrant further investigation. The
majority of changes seen 24 h after treatment with 100 mg/ml
TiO2 indicate activation of cellular stress and reduced
metabolic capacity. These changes expand, at the biochem-
ical and molecular level, previous observations of cytotoxicity
associated with TiO2-NP. In our experimental conditions, we
did not detect any effect on cell viability, which may reflect the
relatively brief (24 h) exposure. This would suggest that
metabolic effects precede effects on viability. Dermal expo-
sure is important not only for the general population in the use
of topically applied cosmetics but also, more importantly,
for workers exposed occupationally in the manufacture of
TiO2-NP. As our short-term study has shown significant
(and potentially pathogenic) metabolic changes, it is evident
that longer-term systematic in vivo studies are required to
fully inform risk assessment and management.
Materials and Methods
Cell culture. The human keratinocyte cell line (HaCaT) was obtained from the
American Type Culture Collection (ATCC). The cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) (Gibco, Paisley, UK) supplemented with 2mM
L-glutamine, 10% fetal bovine serum (FBS) and 1% pen/strep. The cultures were
maintained at 37 1C and 5% CO2.
Titanium dioxide solution preparation and treatment. Anatase
titanium dioxide (TiO2) nanopowder was purchased from Sigma (St. Louis, MO,
USA). The stock solution of TiO2 nanoparticles (1mg/ml) was prepared in
deionized water, dispersed for 10min by using a sonicator (60 amplitude) to
prevent aggregation and vortexed for 1min. The stock solution of titanium dioxide
nanoparticles was kept at 4 1C and used within 1 week for the experiments. Prior
to each experiment, the stock solution was sonicated on ice for 10min, vortexed
for 1 min and then immediately diluted into the working concentrations with
medium. TiO2-NP at different concentrations (5, 50 and 100mg/ml) was added to
the cell cultures containing 20ml of medium in 150mm polystyrene-coated dishes.
After 24-h incubation, cells were harvested and prepared for metabolomic and
other analysis.
Transmission electron microscopy (TEM). For electron microscopy,
cells were fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) at
4 1C overnight and postfixed with 1% osmium tetroxide/1% potassium ferrocyanide
for 1 h at room temperature. After fixation, cells were stained en bloc with 5%
aqueous uranyl acetate overnight at room temperature, dehydrated and
embedded in Taab epoxy resin (Taab Laboratories Equipment Ltd., Aldermaston,
UK). Ultrathin sections were stained with lead citrate and recorded using a
Megaview 3 digital camera and iTEM software (Olympus Soft Imaging Solutions
GmbH, Mu¨nster, Germany) in a Jeol 100-CXII electron microscope (Jeol UK Ltd.,
Welwyn Garden City, UK) equipped with a PCXA-1186 energy-dispersive X-ray
spectrometer (Link Analytical Ltd., High Wycombe, UK).
Flow cytometry analysis. Flow cytometry was performed as described by
Tucci et al.60 Briefly, HaCaT cells were harvested after treatment with 0.025%
trypsin for 3min at 37 1C and then, after addition of 10% FCS in PBS, the cells
were centrifuged, washed with PBS and fixed in 70% cold ethanol. The harvesting
of cells using these conditions led to a high yield of undamaged cells. After
fixation, cells were washed with PBS, treated for 15min at 37 1C with RNase
(100mg/ml) and then stained with propidium iodide (10 mg/ml in the dark for
30min). The samples were then analyzed using a FACScan flow cytometer
(Becton Dickinson, San Jose, CA, USA).
Extracellular flux (XF) analysis. HaCaT cells were seeded in XF 24-well
cell culture microplates (Seahorse Bioscience, North Billerica, MA, USA) in
triplicate at 10 103 cells/well in 1 ml growth medium and then incubated at 37 1C
in 5% CO2. Assays were initiated, 24 h after treatment with TiO2-NP, by removing
the growth medium from each well and replacing it with 600–900ml of assay
medium pre-warmed to 37 1C. The cells were incubated at 37 1C for 30min to
allow media temperature and pH to reach equilibrium before the first rate
measurement. Prior to each rate measurement, the XF24 Analyzer (Seahorse
Bioscience) gently mixed the assay media in each well for 10min to allow the
oxygen partial pressure to reach equilibrium. Following mixing, oxygen
consumption rate (OCR) and extracellular acidification rate (ECAR) were
measured simultaneously for 3–5min to establish a baseline rate. The assay
medium was then gently mixed again for 3–5 min between each rate measurement
to restore normal oxygen tension and pH in the microenvironment surrounding the
cells. After the baseline measurement, 75–90ml of a testing agent prepared in
assay medium was then injected into each well to reach the desired final working
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concentration. This was followed by mixing for 5–10min to expedite compound
exposure to cellular proteins, after which OCR and ECAR measurements were
then carried out. Generally, two to three baseline rates and two or more response
rates (after compound addition) were measured, and the average of two baseline
rates or test rates was used for data analysis. For time-resolved experiments,
multiple measurements as well as compound injections were made at the time
points indicated. The values of OCR and ECAR reflect both the metabolic activities
of the cells and the number of cells being measured. For relative measurements
comparing metabolic rate after compound exposure to a pre-exposure baseline,
that is, when data are expressed as a percentage of OCR or ECAR change over
baseline, the number of cells present in a well is not relevant as the same cell
population is assayed.
Metabolomic analysis. Samples were immediately stored at  80 1C, and,
at the time of analysis, were extracted and prepared for analysis using a standard
metabolic solvent extraction method. The extracted samples were split into equal
parts for analysis by gas chromatography/mass spectrometry (GC/MS) or liquid
chromatography/mass spectrometry (LC/MS/MS) platforms. Also included were
several technical replicate samples created from a homogeneous pool containing
a small amount of all study samples. Global biochemical profiles, from untreated
HaCaT cells (control, CTRL) and cells treated for 24 h with varying doses of TiO2
nanoparticles: 5mg/ml, 50mg/ml, and 100mg/ml, were compared.
The LC/MS portion of the platform was based on a Waters ACQUITY UPLC
(Waters, Milford, MA, USA) and a Thermo-Finnigan LTQ mass spectrometer
(Thermo Electron Corporation, San Jose, CA, USA), which consisted of an
electrospray ionization source and linear ion-trap mass analyzer. The sample
extract was split into two aliquots, dried, then reconstituted in acidic or basic LC-
compatible solvents, each of which contained 11 or more injection standards at fixed
concentrations. One aliquot was analyzed using acidic positive ion-optimized
conditions and the other using basic negative ion-optimized conditions in two
independent injections using separate dedicated columns. Extracts reconstituted in
acidic conditions were gradient-eluted using water and methanol, both containing
0.1% formic acid, while the basic extracts, which also used water/methanol,
contained 6.5 mM ammonium bicarbonate. The MS analysis alternated between MS
and data-dependent MS2 scans using dynamic exclusion.
The samples destined for GC/MS analysis were redried under vacuum
desiccation for a minimum of 24 h prior to being derivatized under dried nitrogen
using bistrimethyl-silyl-triflouroacetamide (BSTFA). The GC column was 5% phenyl
and the temperature ramp is from 40 to 300 1C in a 16min period. Samples were
analyzed on a Thermo-Finnigan Trace DSQ fast-scanning single-quadrupole mass
spectrometer using electron impact ionization. The instrument was tuned and
calibrated for mass resolution and mass accuracy on a daily basis. The information
output from the raw data files was automatically extracted.
For ions with counts 42 million, an accurate mass measurement could be
performed. Accurate mass measurements could be made on the parent ion as well
as on the fragments. The typical mass error was o5 ppm. Ions with o2 million
counts require a greater amount of effort to characterize. Fragmentation spectra
(MS/MS) were typically generated in a data-dependent manner, but if necessary,
targeted MS/MS could be employed, such as in the case of lower level signals.
Compounds were identified by comparison with library entries of purified standards
or recurrent unknown entities. Identification of known chemical entities was based
on comparison with metabolic library entries of purified standards. The combination
of chromatographic properties and mass spectra gave an indication of a match to
the specific compound or an isobaric entity.
Data quality: instrument and process variability. Instrument
variability was determined by calculating the median relative S.D. for the internal
standards that were added to each sample prior to injection into the mass
spectrometers. Overall process variability was determined by calculating the
median relative S.D. for all endogenous metabolites (i.e., non-instrument
standards) present in 100% of the matrix samples, which are technical replicates
of pooled client samples.
Metabolite summary and significantly altered biochemicals. The
metabolic analysis, as from above, allowed the identification of a total of 268
named biochemicals. Following normalization to total protein determined by
Bradford assay, log transformation and imputation with minimum observed values
was performed for each compound. Welc’s two-sample t-tests were then used to
identify biochemicals that differed significantly between experimental groups.
A summary of the numbers of biochemicals that achieved statistical significance
(Pp0.05), as well as those approaching significance (0.05oPo0.1), is shown as
a table and a Supplementary table in the Results section.
An estimate of the false discovery rate (q-value) is calculated to take into account
the multiple comparisons that normally occur in metabolic-based studies. For
example, when analyzing 200 compounds, we would expect to see about 10
compounds meeting the Pp0.05 cutoff by random chance. The q-value describes
the false discovery rate; a low q-value (qo0.10) is an indication of high confidence
in a result. While a higher q-value indicates diminished confidence, it does not
necessarily rule out the significance of a result.
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